AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 26 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $576,000 | +30.3% | 116,923 | +1.8% | 0.00% | 0.0% |
| Q2 2017 | $442,000 | -49.8% | 114,834 | -2.9% | 0.00% | -42.9% |
| Q1 2017 | $881,000 | +69.1% | 118,314 | -1.2% | 0.01% | +75.0% |
| Q4 2016 | $521,000 | -25.9% | 119,707 | +9.2% | 0.00% | -42.9% |
| Q3 2016 | $703,000 | +44.7% | 109,645 | +9.6% | 0.01% | +40.0% |
| Q2 2016 | $486,000 | – | 100,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yu Fan | 112,044 | $532,000 | 6.17% |
| Aisling Capital Management LP | 1,691,151 | $8,033,000 | 2.83% |
| Bain Capital Life Sciences Investors, LLC | 2,847,689 | $13,527,000 | 1.07% |
| GREAT POINT PARTNERS LLC | 910,251 | $4,324,000 | 0.96% |
| Samsara BioCapital, LLC | 883,720 | $4,198,000 | 0.81% |
| Sio Capital Management, LLC | 498,500 | $2,368,000 | 0.71% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $1,167,000 | 0.53% |
| Nantahala Capital Management | 2,813,560 | $13,364,000 | 0.47% |
| Altium Capital Management LP | 293,764 | $1,395,000 | 0.38% |
| Lion Point Capital, LP | 300,000 | $1,425,000 | 0.38% |